Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Phathom Pharmaceuticals
PHAT
$743M
| $2.11M | ﹤0.01% |
+67,787
| New | +$1.7M |
|
2402
FRP Holdings
FRPH
$425M
| $2.1M | ﹤0.01% |
84,440
+1,248
| +2% | +$31.4K |
|
2403
Napco Security Technologies
NSSC
$1.37B
| $2.07M | ﹤0.01% |
140,550
+3,538
| +3% | +$51.3K |
|
2404
Peoples Financial Services
PFIS
$717M
| $2.06M | ﹤0.01% |
40,862
+631
| +2% | +$30.9K |
|
|
TBRG
2405
DELISTED
TruBridge
TBRG
| $2.06M | ﹤0.01% |
77,925
+1,951
| +3% | +$48.7K |
|
2406
Sportsman's Warehouse
SPWH
$46.8M
| $2.05M | ﹤0.01% |
254,749
+19,465
| +8% | +$138K |
|
2407
Energy Recovery
ERII
$399M
| $2.04M | ﹤0.01% |
208,526
+248
| +0.1% | +$2.29K |
|
|
SDC
2408
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $2.03M | ﹤0.01% |
+232,168
| New | +$2.32M |
|
2409
Quanterix
QTRX
$135M
| $2.03M | ﹤0.01% |
85,796
+3,964
| +5% | +$90.5K |
|
2410
SI-BONE Inc
SIBN
$849M
| $2.03M | ﹤0.01% |
94,256
+2,500
| +3% | +$44.9K |
|
2411
VSE Corp
VSEC
$6.48B
| $2.02M | ﹤0.01% |
53,058
+1,324
| +3% | +$49.3K |
|
|
ORBC
2412
DELISTED
ORBCOMM, Inc.
ORBC
| $2.02M | ﹤0.01% |
478,732
+5,680
| +1% | +$24.3K |
|
|
CAMP
2413
DELISTED
CalAmp Corp.
CAMP
| $2.01M | ﹤0.01% |
9,139
+366
| +4% | +$89.2K |
|
|
HUD
2414
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $2.01M | ﹤0.01% |
131,120
+3,102
| +2% | +$40.5K |
|
2415
Astrana Health
ASTH
$1.87B
| $2.01M | ﹤0.01% |
109,159
-44,688
| -29% | -$741K |
|
|
RUBY
2416
DELISTED
Rubius Therapeutics, Inc
RUBY
| $2M | ﹤0.01% |
210,493
+3,499
| +2% | +$33.8K |
|
|
EXPR
2417
DELISTED
Express, Inc.
EXPR
| $2M | ﹤0.01% |
20,515
+674
| +3% | +$53K |
|
2418
Tejon Ranch
TRC
$443M
| $2M | ﹤0.01% |
125,002
+1,422
| +1% | +$23.2K |
|
|
VSLR
2419
DELISTED
VIVINT SOLAR, INC.
VSLR
| $2M | ﹤0.01% |
274,961
+5,990
| +2% | +$42.3K |
|
|
AGS
2420
DELISTED
PlayAGS
AGS
| $1.98M | ﹤0.01% |
163,412
-100,761
| -38% | -$1.15M |
|
2421
Surgery Partners
SGRY
$1.99B
| $1.98M | ﹤0.01% |
126,591
-1,129
| -0.9% | -$12.8K |
|
|
REVG
2422
DELISTED
REV Group
REVG
| $1.98M | ﹤0.01% |
161,546
+3,932
| +2% | +$49.7K |
|
2423
Consolidated Water Co
CWCO
$502M
| $1.97M | ﹤0.01% |
121,015
| – | – |
|
2424
Future Fuel
FF
$249M
| $1.97M | ﹤0.01% |
159,241
+3,817
| +2% | +$45.5K |
|
|
PING
2425
DELISTED
Ping Identity Holding Corp.
PING
| $1.96M | ﹤0.01% |
+80,718
| New | +$1.55M |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.